Yasin Ozcan1, Gumus Huseyin2, Kenan Sonmez3. 1. Yeditepe University, Faculty of Medicine, Ophthalmology Department, Istanbul, Turkey. 2. Harran University, Medical School Hospital, Neonatology Department, Sanliurfa, Turkey. 3. University of Health Sciences, Ulucanlar Eye Education and Research Hospital, Ophthalmology Department, Ankara, Turkey.
Abstract
AIM: The aim of this study is to ascertain whether the level of circulating amino acids (aa) is associated with retinopathy of prematurity (ROP). METHODS: This is a randomized controlled study of 55 infants born at gestational age (GA) ≤32 weeks or birth weight (BW) ≤1500 grams. Serum samples were obtained from two groups: Group A comprised of 26 preterm infants with ROP and Group B comprised of 29 preterm infants without ROP. Plasma aa levels were analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Correlation test and multivariate regression analysis were used to evaluate the relationship between plasma aa levels and variables. RESULTS: The mean serum arginine and glutamine levels were significantly higher, but the mean lysine and aspartic acid levels were significantly lower in Group A, compared to Group B (p = 0.04, p = 0.002, p = 0.029, and p = 0.002, respectively). In multivariate analysis, the mean arginine and lysine levels were significantly associated with the stage of the disease (p = 0.03 and p = 0.01, respectively). No significant differences were determined between the groups in terms of alanine, asparagine, valine, leucine, phenylalanine, tyrosine, serine, proline, citrulline, cysteine, ornithine, tryptophan, methionine, threonine, taurine, and isoleucine amino acids (p > 0.05, respectively). CONCLUSIONS: These results indicate a significant association between high arginine and glutamine, with low lysine and aspartic acid serum concentrations with ROP. Due to higher serum concentrations in ROP, extra arginine-glutamine supplementation in hyperoxic conditions may be unfavorable through pathways involving reactive oxygen, particularly in patients with ROP.
AIM: The aim of this study is to ascertain whether the level of circulating amino acids (aa) is associated with retinopathy of prematurity (ROP). METHODS: This is a randomized controlled study of 55 infants born at gestational age (GA) ≤32 weeks or birth weight (BW) ≤1500 grams. Serum samples were obtained from two groups: Group A comprised of 26 preterm infants with ROP and Group B comprised of 29 preterm infants without ROP. Plasma aa levels were analyzed using liquid chromatography with tandem mass spectrometry (LC-MS/MS). Correlation test and multivariate regression analysis were used to evaluate the relationship between plasma aa levels and variables. RESULTS: The mean serum arginine and glutamine levels were significantly higher, but the mean lysine and aspartic acid levels were significantly lower in Group A, compared to Group B (p = 0.04, p = 0.002, p = 0.029, and p = 0.002, respectively). In multivariate analysis, the mean arginine and lysine levels were significantly associated with the stage of the disease (p = 0.03 and p = 0.01, respectively). No significant differences were determined between the groups in terms of alanine, asparagine, valine, leucine, phenylalanine, tyrosine, serine, proline, citrulline, cysteine, ornithine, tryptophan, methionine, threonine, taurine, and isoleucine amino acids (p > 0.05, respectively). CONCLUSIONS: These results indicate a significant association between high arginine and glutamine, with low lysine and aspartic acid serum concentrations with ROP. Due to higher serum concentrations in ROP, extra arginine-glutamine supplementation in hyperoxic conditions may be unfavorable through pathways involving reactive oxygen, particularly in patients with ROP.
Authors: Josef Neu; Aqeela Afzal; Hao Pan; Esteban Gallego; Nan Li; Sergio Li Calzi; Sergio Caballero; Polyxenie E Spoerri; Lynn C Shaw; Maria B Grant Journal: Invest Ophthalmol Vis Sci Date: 2006-07 Impact factor: 4.799
Authors: D Darmaun; A Lapillonne; U Simeoni; J-C Picaud; J-C Rozé; E Saliba; A Bocquet; J-P Chouraqui; C Dupont; F Feillet; M-L Frelut; J-P Girardet; D Turck; A Briend Journal: Arch Pediatr Date: 2018-04-12 Impact factor: 1.180
Authors: S R D van der Schoor; P J Reeds; F Stellaard; J D L Wattimena; P J J Sauer; H A Büller; J B van Goudoever Journal: Gut Date: 2004-01 Impact factor: 23.059
Authors: Kip M Connor; John Paul SanGiovanni; Chatarina Lofqvist; Christopher M Aderman; Jing Chen; Akiko Higuchi; Song Hong; Elke A Pravda; Sharon Majchrzak; Deborah Carper; Ann Hellstrom; Jing X Kang; Emily Y Chew; Norman Salem; Charles N Serhan; Lois E H Smith Journal: Nat Med Date: 2007-06-24 Impact factor: 53.440
Authors: Lynn Calvin Shaw; Sergio Li Calzi; Nan Li; Leni Moldovan; Nilanjana Sengupta-Caballero; Judith Lindsey Quigley; Mircea Ivan; Bokkyoo Jun; Nicolas G Bazan; Michael Edwin Boulton; Julia Busik; Josef Neu; Maria B Grant Journal: Invest Ophthalmol Vis Sci Date: 2018-02-01 Impact factor: 4.799